Cell therapy · FDA · US patients · 2030

Customized stem cell therapy for all US patients

Evidence first, for patients, clinicians and researchers: what FDA has approved, the trial results behind it, and how to tell real therapy from an unproven clinic.

Curated by Dr. Javid Ur Rahaman, Head of Applied Intelligence, AAI Applied Agentic Intelligence Research Labs®

30 FDA-approved successes, sourced55 FDA-licensed productsFigures checked against FDA labels, Nov 2026drjavid.bio

Who are you?

I am one of the

Patients & families

Find out what is proven, what is not, and how to spot an unsafe clinic.

I am one of the

Clinicians

Look up approved products by condition, the evidence behind them, and where to refer.

I am one of the

Researchers & sponsors

Work out your regulatory tier and plan the route to an approved product.

Where things stand (Nov 2026): FDA continues to act against clinics selling unapproved stem cell products. No FDA policy today lets a whole class of facility, such as urgent care, make or give customized cell therapies. The 2030 roadmap is a scenario, not FDA policy.

Explore